Table 6.

Univariate analysis by race and cytogenetic risk

	Whites w t(11;14) w/o high risk cytogenetics (N = 193)		AA w t(11;14) w/o high risk cytogenetics (N = 92)		Whites w t(11;14) w high risk cytogenetics (N = 73)		AA w t(11;14) w high risk cytogenetics (N = 25)
Outcomes	N	Prob (95% CI)	N	Prob (95% CI)	N	Prob (95% CI)	N	Prob (95% CI)	p-value
Progression free survival	188		92		71		23		0.02
1-year		78 (72–84)%		83 (75–90)%		69 (57–79)%		86 (70–97)%	0.14
2-year		59 (51–66)%		61 (50–72)%		38 (25–51)%		NE	0.003
Overall survival	193		92		73		25		0.13
1-year		93 (89–96)%		96 (90–99)%		94 (88–98)%		92 (78–99)%	0.83
2-year		89 (84–93)%		93 (86–97)%		75 (62–85)%		NE	0.06

^*Patients without t(11;14) were excluded for this analysis

AA; African Americans, w; with, w/o; without, Prob; probability, CI; confidence interval